Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice A Novel Mechanism Presenting the Protein Fe65 as a Target /

Regulated intramembrane proteolysis (RIP) of the amyloid precursor protein (APP) leads to the formation of fragments, among which the intracellular domain of APP (AICD) was also identified to be a causative of early pathological events. AICD-counteracting proteins, such as Fe65, may serve as alterna...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Szögi Titanilla
Schuster Ildikó
Borbély Emőke
Gyebrovszki Andrea
Bozsó Zsolt
Gera János
Rajkó Róbert
Sántha Miklós
Penke Botond
Fülöp Lívia
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 No. 12
Tárgyszavak:
doi:10.3390/ijms20123050

mtmt:30744451
Online Access:http://publicatio.bibl.u-szeged.hu/22578
LEADER 02527nab a2200337 i 4500
001 publ22578
005 20211006153602.0
008 211005s2019 hu o 0|| zxx d
022 |a 1661-6596 
024 7 |a 10.3390/ijms20123050  |2 doi 
024 7 |a 30744451  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Szögi Titanilla 
245 1 0 |a Effects of the Pentapeptide P33 on Memory and Synaptic Plasticity in APP/PS1 Transgenic Mice  |h [elektronikus dokumentum] :  |b A Novel Mechanism Presenting the Protein Fe65 as a Target /  |c  Szögi Titanilla 
260 |c 2019 
300 |a Terjedelem: 20-Azonosító: 3050 
490 0 |a INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES  |v 20 No. 12 
520 3 |a Regulated intramembrane proteolysis (RIP) of the amyloid precursor protein (APP) leads to the formation of fragments, among which the intracellular domain of APP (AICD) was also identified to be a causative of early pathological events. AICD-counteracting proteins, such as Fe65, may serve as alternative therapeutic targets of Alzheimer's disease (AD). The detection of elevated levels of Fe65 in the brains of both human patients and APP transgenic mice may further strengthen the hypothesis that influencing the interaction between Fe65 and APP may have a beneficial effect on the course of AD. Based on a PXP motif, proven to bind to the WW domain of Fe65, a new pentapeptide was designed and tested. The impedimental effect of P33 on the production of beta amyloid (A beta) (soluble fraction and aggregated plaques) and on the typical features of the AD pathology (decreased dendritic spine density, synaptic markers, elevated inflammatory reactions) was also demonstrated. Significant enhancements of both learning ability and memory function were observed in a Morris water maze paradigm. The results led us to formulate the theory that P33 acts by altering the conformation of Fe65 via binding to its WW domain, consequently hindering any interactions between Fe65 and key members involved in APP processing. 
650 4 |a Általános orvostudomány 
650 4 |a Pszichológia 
700 0 1 |a Schuster Ildikó  |e aut 
700 0 1 |a Borbély Emőke  |e aut 
700 0 1 |a Gyebrovszki Andrea  |e aut 
700 0 1 |a Bozsó Zsolt  |e aut 
700 0 1 |a Gera János  |e aut 
700 0 1 |a Rajkó Róbert  |e aut 
700 0 1 |a Sántha Miklós  |e aut 
700 0 1 |a Penke Botond  |e aut 
700 0 1 |a Fülöp Lívia  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/22578/1/Szogiijms-20-03050.pdf  |z Dokumentum-elérés